Proscia: Rewiring cancer diagnosis through digitization and AI to improve patient outcomes Philadelphia – November 20, 2024 – Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, was named to Fast...

Owkin’s MSIntuit® CRC v2*, a next-generation AI diagnostic aimed at transforming the detection and treatment of colorectal cancer, will be integrated into Proscia’s Concentriq® software platform, making it available as part of...

Proscia & Bioptimus: Explore how foundation models can transform novel AI development in pathology Unlocking the Promise of Foundation Models in Pathology for AI-Driven Drug Discovery & Development November 6, 11:00 AM — 12:00...

Bioptimus’ H-optimus-0 Foundation Model Now Available with Proscia’s Concentriq® Embeddings for Rapid AI Development With 1.1 billion parameters, H-optimus-0 is the largest open-source AI foundation model tailored specifically for...

Proscia: 2024 Emerging Solutions Top 20 winners celebrated at HLTH USA PHILADELPHIA – OCTOBER 22, 2024 – Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, was named to KLAS Research’s 2024 Emerging...

Proscia has announced a webinar. From Bedside to Bench and Back: How Digital Pathology is Fueling Precision Medicine with Unprecedented Real-World Data October 30 11:00 AM — 12:00 PM EDT Register Join us for a panel discussion on...